VPS45 anticorps (C-Term)
Aperçu rapide pour VPS45 anticorps (C-Term) (ABIN207533)
Antigène
Voir toutes VPS45 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Synthetic peptide corresponding to C-terminal residues of human VPS45A (vacuolar protein sorting 45A)
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide from human VPS45.
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: ELISA (1 μg/mL), WB (1 μg/mL)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.01 % sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- VPS45 (Vacuolar Protein Sorting 45 (VPS45))
-
Autre désignation
- VPS45
-
Sujet
-
Name/Gene ID: VPS45
Synonyms: VPS45, H1, H1VPS45, VPS45B, VPS54A, VSP45, VSP45A, H-vps45, HlVps45, Vacuolar protein sorting 45A, VPS45A -
ID gène
- 11311
-
UniProt
- Q9NRW7
-
Pathways
- Transition Metal Ion Homeostasis, Synaptic Vesicle Exocytosis
Antigène
-